The Royal Marsden NHS Foundation Trust

Unit G3, Harbour Yard, Chelsea Harbour

London

SW10 0XD

UK

Contact person: tenders@chelwest.nhs.uk

E-mail: tenders@chelwest.nhs.uk

NUTS: UKI

Internet address(es)

Main address: www.royalmarsden.nhs.uk

Address of the buyer profile: www.royalmarsden.nhs.uk

II.1.1) Title

Reference number: DN496124

II.1.2) Main CPV code

33100000

II.1.3) Type of contract

Supplies

II.1.4) Short description

The Royal Marsden Hospital NHS Foundation Trust needs to purchase Trinity MR/US fusion prostate biopsy system. This machine is central to delivering the RAPID programme. The Trust currently undertakes TRUS biopsies in the outpatient setting. TRUS biopsies are associated with a high level of sepsis (as the bx is taken via the rectum and not the perineum) therefore the Trust has to move to transperineal biospies to prevent this.

II.1.6) Information about lots

This contract is divided into lots: No

II.1.7) Total value of the procurement

Value excluding VAT: 170 000.00  GBP

IV.1.1) Type of procedure

Award of a contract without prior publication of a call for competition

Justification for selected award procedure:

The procurement falls outside the scope of application of the Directive

Explanation:

The Trust intend to award Koelis for this purchase as there is no alternative machine on the market.

Koelis machine has several features which are required by the Trust:

1) Organ based tracking — tracks the shifting prostate and automatically compensates for these movements using solely the images and without any additional sensors therefore maximising the accuracy of the procedure and reducing the number of core biopsies needed to be undertaken by 1/3rd.

2) Free-hand biopsy capability — low cost disposable guides are available to facilitate this process.

3) Elastic fusion — the MRI scans are superimposed then automatically adjusted to better correspond to the contours of the ultrasound images in real time.

4) Koelis system facilitates biopsy in left lateral position (patient is lying on their side) as opposed to lithotomy position. The system can operates in such position even for the transperineal approach under local anesthesia. This makes the procedure more comfortable tolerable and the patient moves less. There is also pressure point protection (minimising chance of neuropraxia), which increases the speed of biopsy meaning more can be done during a session this significantly increases efficiency.

5) Highly portable system which doesn’t require recalibrating when moved. This means a single integrated device which can be moved between hospital sites to maximise use of the equipment.

6) Koelis technology allows to perform virtual biopsy which provides to the clinician the ability to plan and check with high precision the needle positioning before actually performing the biopsy/intervention.

7) The second Look feature can recall a previous prostate 3D-mapping and fuse it to the live session as a plan to target unexplored area or previous positive biopsies. This is of paramount importance for the management of active surveillance patients, as well as an entry point to focal therapy planning.

IV.1.8) Information about Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: No

Koelis Advancing Prostate Care

Meylan

UK

NUTS: UKI

The contractor is an SME: No

VI.4.1) Review body